Katherine Bever
0000-0001-5230-4661
43 papers found
Refreshing results…
Supplementary Figure 2 from Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer
Supplementary Figure 1 from Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer
Supplementary Table 3 from Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer
Supplementary Table 2 from Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer
FIGURE 2 from Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer
FIGURE 1 from Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer
Data from Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer
TABLE 2 from Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer
TABLE 1 from Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer
Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer
Supplementary Table 1 from Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer
Supplementary Figure 2 from Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan (GTX-CI) as First-line Treatment for Metastatic Pancreatic Cancer
Supplementary Table 3 from Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan (GTX-CI) as First-line Treatment for Metastatic Pancreatic Cancer
Supplementary Table 2 from Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan (GTX-CI) as First-line Treatment for Metastatic Pancreatic Cancer
Supplementary Figure 1 from Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan (GTX-CI) as First-line Treatment for Metastatic Pancreatic Cancer
Data from Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan (GTX-CI) as First-line Treatment for Metastatic Pancreatic Cancer
Supplementary Table 1 from Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan (GTX-CI) as First-line Treatment for Metastatic Pancreatic Cancer
Data from Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal Adenocarcinoma
Figure S3 from Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal Adenocarcinoma
Figure S2 from Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal Adenocarcinoma
Missing publications? Search for publications with a matching author name.